Paper39723908
TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance.
Knaab TC and 15 others. J Med Chem, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance. Papers, record 39723908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39723908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Plasmodium falciparum | Major topic |
| Drug Resistance | Major topic |
| Mice, SCID | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Structure-Activity Relationship | |
| Malaria | |
| Plasmodium berghei | |
| Amidines | |
| Malaria, Falciparum | |
| Hemeproteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI109023 | NIAID NIH HHS | United States | R01AI109023 | PubMed and NIH |
Source NIH RePORTER
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25453091 | (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25453091 | PubMed |
| 2 | 14729380 | Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. | Eur J Pharmacol | 2004 | https://conductscience.org/library/papers/14729380 | PubMed |
| 3 | 31109978 | Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31109978 | PubMed |
| 4 | 35096650 | Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/35096650 | PubMed |
| 5 | 28653845 | 3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally. | J Med Chem | 2017 | https://conductscience.org/library/papers/28653845 | PubMed |
| 6 | 18493601 | A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. | PLoS One | 2008 | https://conductscience.org/library/papers/18493601 | PubMed |
| 7 | 25114138 | Antimalarial activity of the myxobacterial macrolide chlorotonil a. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25114138 | PubMed |
| 8 | 19596869 | Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19596869 | PubMed |
| 9 | 15745752 | A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds. | Anal Biochem | 2005 | https://conductscience.org/library/papers/15745752 | PubMed |
| 10 | 20230372 | Lipophilic mediated assays for beta-hematin inhibitors. | Comb Chem High Throughput Screen | 2010 | https://conductscience.org/library/papers/20230372 | PubMed |
| 11 | 22096101 | Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. | Science | 2011 | https://conductscience.org/library/papers/22096101 | PubMed |
| 12 | 25516843 | Identification of β-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity. | Int J Parasitol Drugs Drug Resist | 2014 | https://conductscience.org/library/papers/25516843 | PubMed |
| 13 | 33126289 | Low-volume LC-MS/MS method for the pharmacokinetic investigation of carvedilol, enalapril and their metabolites in whole blood and plasma: Application to a paediatric clinical trial. | Drug Test Anal | 2021 | https://conductscience.org/library/papers/33126289 | PubMed |
| 14 | 38321292 | Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa. | Nat Rev Microbiol | 2024 | https://conductscience.org/library/papers/38321292 | PubMed |
| 15 | 34001441 | Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. | Trends Parasitol | 2021 | https://conductscience.org/library/papers/34001441 | PubMed |
| 16 | 28225668 | Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28225668 | PubMed |
| 17 | 19438171 | Simple size-independent measure of ligand efficiency. | J Chem Inf Model | 2009 | https://conductscience.org/library/papers/19438171 | PubMed |
| 18 | 25487796 | Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25487796 | PubMed |
| 19 | 36471200 | Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method. | AAPS J | 2022 | https://conductscience.org/library/papers/36471200 | PubMed |
| 20 | 26085270 | A novel multiple-stage antimalarial agent that inhibits protein synthesis. | Nature | 2015 | https://conductscience.org/library/papers/26085270 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42732910 | Tearing Down Scientific Boundaries: Frontiers in Medicinal Chemistry 2026. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42732910 | PubMed |
| 41808149 | Integrative preclinical strategy for pharmacokinetic profiling and candidate selection of 3-hydroxypropanamidines: a promising antimalarial class. | Malar J | 2026 | https://conductscience.org/library/papers/41808149 | PubMed |
| 40921080 | Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity. | J Med Chem | 2025 | https://conductscience.org/library/papers/40921080 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39723908
GET https://conductscience.org/api/papers/v1/39723908/references?page=2